FONTEYNE PAUL R. 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+19,000→ 19,000 totalExercise: $13.56Exp: 2032-06-09→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.